IT202000001831A1 - COMPOSITION FOR RECTAL APPLICATION BASED ON BUTYRIC ACID SALT FOR THE TREATMENT OF PROCTOLOGICAL PATHOLOGIES - Google Patents

COMPOSITION FOR RECTAL APPLICATION BASED ON BUTYRIC ACID SALT FOR THE TREATMENT OF PROCTOLOGICAL PATHOLOGIES

Info

Publication number
IT202000001831A1
IT202000001831A1 IT102020000001831A IT202000001831A IT202000001831A1 IT 202000001831 A1 IT202000001831 A1 IT 202000001831A1 IT 102020000001831 A IT102020000001831 A IT 102020000001831A IT 202000001831 A IT202000001831 A IT 202000001831A IT 202000001831 A1 IT202000001831 A1 IT 202000001831A1
Authority
IT
Italy
Prior art keywords
treatment
composition
acid salt
butyric acid
application based
Prior art date
Application number
IT102020000001831A
Other languages
Italian (it)
Inventor
Cristian Salvatore
Nicola Danzo
Original Assignee
Caprika Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caprika Srl filed Critical Caprika Srl
Priority to IT102020000001831A priority Critical patent/IT202000001831A1/en
Priority to PCT/IB2021/050659 priority patent/WO2021152492A1/en
Priority to EP21708364.1A priority patent/EP4096629A1/en
Publication of IT202000001831A1 publication Critical patent/IT202000001831A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT102020000001831A 2020-01-30 2020-01-30 COMPOSITION FOR RECTAL APPLICATION BASED ON BUTYRIC ACID SALT FOR THE TREATMENT OF PROCTOLOGICAL PATHOLOGIES IT202000001831A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT102020000001831A IT202000001831A1 (en) 2020-01-30 2020-01-30 COMPOSITION FOR RECTAL APPLICATION BASED ON BUTYRIC ACID SALT FOR THE TREATMENT OF PROCTOLOGICAL PATHOLOGIES
PCT/IB2021/050659 WO2021152492A1 (en) 2020-01-30 2021-01-28 Butyric acid salt-based composition for rectal application for the treatment of proctology disorders
EP21708364.1A EP4096629A1 (en) 2020-01-30 2021-01-28 Butyric acid salt-based composition for rectal application for the treatment of proctology disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102020000001831A IT202000001831A1 (en) 2020-01-30 2020-01-30 COMPOSITION FOR RECTAL APPLICATION BASED ON BUTYRIC ACID SALT FOR THE TREATMENT OF PROCTOLOGICAL PATHOLOGIES

Publications (1)

Publication Number Publication Date
IT202000001831A1 true IT202000001831A1 (en) 2021-07-30

Family

ID=70480457

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102020000001831A IT202000001831A1 (en) 2020-01-30 2020-01-30 COMPOSITION FOR RECTAL APPLICATION BASED ON BUTYRIC ACID SALT FOR THE TREATMENT OF PROCTOLOGICAL PATHOLOGIES

Country Status (3)

Country Link
EP (1) EP4096629A1 (en)
IT (1) IT202000001831A1 (en)
WO (1) WO2021152492A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023170597A1 (en) * 2022-03-08 2023-09-14 Sila S.P.A. Topical composition for treating injuries or cutaneous inflammatory states or proctological pathologies

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0731705A1 (en) * 1993-12-02 1996-09-18 Alfred Schmidt Use of dimeticone for treating constipation
WO2009068215A1 (en) * 2007-11-27 2009-06-04 Sigea S.R.L. Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics
US20100080768A1 (en) * 2008-09-26 2010-04-01 Mcgraw Thomas L Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin
KR20110035312A (en) * 2009-09-30 2011-04-06 일동제약주식회사 Effective treatment for hemorrhoids using hyaluronic acid
WO2016113192A1 (en) * 2015-01-13 2016-07-21 Sigea S.R.L. Process in water for the preparation of butyric esters of hyaluronic acid sodium salt
WO2020141986A1 (en) * 2018-12-30 2020-07-09 Jamjoom Pharmaceuticals Factory Company Limited Silicone gel composition containing hyaluronic acid and/or its salt for prevention and repair of skin scars

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0731705A1 (en) * 1993-12-02 1996-09-18 Alfred Schmidt Use of dimeticone for treating constipation
WO2009068215A1 (en) * 2007-11-27 2009-06-04 Sigea S.R.L. Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics
US20100080768A1 (en) * 2008-09-26 2010-04-01 Mcgraw Thomas L Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin
KR20110035312A (en) * 2009-09-30 2011-04-06 일동제약주식회사 Effective treatment for hemorrhoids using hyaluronic acid
WO2016113192A1 (en) * 2015-01-13 2016-07-21 Sigea S.R.L. Process in water for the preparation of butyric esters of hyaluronic acid sodium salt
WO2020141986A1 (en) * 2018-12-30 2020-07-09 Jamjoom Pharmaceuticals Factory Company Limited Silicone gel composition containing hyaluronic acid and/or its salt for prevention and repair of skin scars

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KATARZYNA BORYCKA-KICIAK ET AL: "Butyric acid - a well-known molecule revisited", GASTROENTEROLOGY REVIEW, vol. 2, 1 January 2017 (2017-01-01), pages 83 - 89, XP055739041, ISSN: 1895-5770, DOI: 10.5114/pg.2017.68342 *

Also Published As

Publication number Publication date
WO2021152492A1 (en) 2021-08-05
EP4096629A1 (en) 2022-12-07

Similar Documents

Publication Publication Date Title
MA47308A (en) CHEMICAL COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY
CY1122139T1 (en) USE OF PUFAS FOR THE TREATMENT OF SKIN INFLAMMATION
CY2020032I2 (en) PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES CAUSED BY MICROBES
CY1121071T1 (en) NAPTHYRIDINE PRODUCTS AS INTEGRIN ALPHA V ALBONE V BETA 6 COMPETITORS FOR THERAPY BC FIBROID DISEASES
MA53388A (en) NLRP3 INHIBITORS OF INFLAMMASOME
CY1118439T1 (en) NEW AGOMELATIN CYCLES
UY30842A1 (en) DERIVATIVES OF N- (AMINO-HETEROARIL) -1H-PIRROLOPIRIDIN-2-CARBOXAMIDAS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
IT202000001831A1 (en) COMPOSITION FOR RECTAL APPLICATION BASED ON BUTYRIC ACID SALT FOR THE TREATMENT OF PROCTOLOGICAL PATHOLOGIES
GB201905940D0 (en) 5-aminolevulinic acid for the local treatment of inflammatory bowel disease
IL278932A (en) Process for the synthesis of (s)-3-amino-4-(difluoromethylenyl)cyclopent-l-ene-l-carboxylic acid
MA56056A (en) NEW EFFICIENT PROCESS FOR THE SYNTHESIS OF 2-AMINO-5-CHLORO-N-,3-DIMETHYLBENZAMIDE
MA49704A (en) ISOTOPIC-LABELED BILIARY ACID DERIVATIVES
MA54907A (en) TOPICAL PHOSPHOINONOSITIDE 3-KINASE INHIBITORS
DK3737470T5 (en) 3-PHENYL-4-HEXYNIC ACID DERIVATIVES AS GPR40 AGONISTS
IT201900025234A1 (en) APPARATUS FOR THE PRODUCTION OF METAL
FR3058909B1 (en) SULFONIC ACID SALTS FOR THE PREPARATION OF METAL CATALYST
JP1759030S (en) head mounted display
FI4132909T3 (en) Organic acid addition salts of s-pindolol
IT201900024117A1 (en) PROCEDURE FOR THE SYNTHESIS OF CROSS-LINKED HYALURONIC ACID
MA52362A (en) PROCESS FOR THE PREPARATION OF 2- (1- (TERT-BUTOXYLCARBONYL) -PIPERIDINE-4-YL) BENZOIC ACID
MA52938A (en) OGA INHIBITOR COMPOUNDS
PA8636801A1 (en) PROCESSES FOR THE PREPARATION OF ALKYL OR BENCILIC ESTERS OF ACID 2-CIANO-3-NAFTALEN-1-IL-ACRYLIC
ES1258595Y (en) ACID CLEANING FORMULATION
CY2021030I1 (en) NEW ACID SULFATE SALT
IT201900024202A1 (en) Biomechatronic device for automated diagnosis of rheumatic diseases